These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 17315171

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 3. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A, Azria D, Pasche P, Stupp R, Chevalier J, Betz M, Mirimanoff RO, Ozsahin M.
    Radiother Oncol; 2004 Feb 01; 70(2):183-8. PubMed ID: 15028406
    [Abstract] [Full Text] [Related]

  • 4. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
    Nuyts S, Dirix P, Clement PM, Poorten VV, Delaere P, Schoenaers J, Hermans R, Van den Bogaert W.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1088-95. PubMed ID: 18707823
    [Abstract] [Full Text] [Related]

  • 5. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K, Tashiro M, Hosono M, Fukuda H, Takada Y, Kondo S, Inoue Y, Iguchi H, Kusuki M, Yamane H.
    Acta Otolaryngol Suppl; 2004 Oct 15; (554):62-6. PubMed ID: 15513514
    [Abstract] [Full Text] [Related]

  • 6. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A, Tans L, Van rooij PH, Noever I, Baatenburg de jong RJ, Levendag PC.
    Acta Oncol; 2009 Oct 15; 48(4):562-70. PubMed ID: 19373698
    [Abstract] [Full Text] [Related]

  • 7. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thöni A, Ozsahin M, Bernier J, Töpfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C.
    J Clin Oncol; 2004 Dec 01; 22(23):4665-73. PubMed ID: 15534360
    [Abstract] [Full Text] [Related]

  • 8. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
    Pehlivan B, Luthi F, Matzinger O, Betz M, Dragusanu D, Bulling S, Bron L, Pasche P, Seelentag W, Mirimanoff RO, Zouhair A, Ozsahin M.
    Ann Surg Oncol; 2009 May 01; 16(5):1337-43. PubMed ID: 19280263
    [Abstract] [Full Text] [Related]

  • 9. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P, Putnik K, Kreimeyer T, Sprague LD, Koelbl O, Schäfer C.
    BMC Cancer; 2006 Dec 07; 6():279. PubMed ID: 17150114
    [Abstract] [Full Text] [Related]

  • 10. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.
    Allal AS, Maire D, Becker M, Dulguerov P.
    Cancer; 2000 Feb 01; 88(3):648-52. PubMed ID: 10649260
    [Abstract] [Full Text] [Related]

  • 11. Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity.
    Lau H, Brar S, Hao D, MacKinnon J, Yee D, Gluck S.
    Head Neck; 2006 Mar 01; 28(3):189-96. PubMed ID: 16265658
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.
    Medina JA, Rueda A, de Pasos AS, Contreras J, Cobo M, Moreno P, Benavides M, Villanueva A, Alba E.
    Radiother Oncol; 2006 Apr 01; 79(1):34-8. PubMed ID: 16626826
    [Abstract] [Full Text] [Related]

  • 13. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, McNair H, Bidmead M, Warrington AP, Dearnaley DP, Harrington KJ, Nutting CM.
    Radiother Oncol; 2007 Oct 01; 85(1):36-41. PubMed ID: 17709149
    [Abstract] [Full Text] [Related]

  • 14. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S, Goda JS, Mallick I, Kehwar TS, Sharma SC.
    Clin Oncol (R Coll Radiol); 2008 Apr 01; 20(3):212-20. PubMed ID: 18343310
    [Abstract] [Full Text] [Related]

  • 15. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
    Chakraborty S, Ghoshal S, Patil V, Oinam A, Suresh S.
    Clin Oncol (R Coll Radiol); 2009 Nov 01; 21(9):676-86. PubMed ID: 19748768
    [Abstract] [Full Text] [Related]

  • 16. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
    Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, Magnuson JS, Spencer SA, Bonner JA.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):410-5. PubMed ID: 18635320
    [Abstract] [Full Text] [Related]

  • 17. Initial clinical experience with helical tomotherapy for head and neck cancer.
    Chen AM, Jennelle RL, Sreeraman R, Yang CC, Liu T, Vijayakumar S, Purdy JA.
    Head Neck; 2009 Dec 01; 31(12):1571-8. PubMed ID: 19405087
    [Abstract] [Full Text] [Related]

  • 18. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
    Duprez F, Madani I, Bonte K, Boterberg T, Vakaet L, Derie C, De Gersem W, De Neve W.
    Radiother Oncol; 2009 Dec 01; 93(3):563-9. PubMed ID: 19919885
    [Abstract] [Full Text] [Related]

  • 19. Hyperfractionated, accelerated chemoradiation with concurrent mitomycin-C and cisplatin in locally advanced head and neck cancer, a phase I/II study.
    Hehr T, Classen J, Welz S, Ganswindt U, Scheithauer H, Koitschev A, Bamberg M, Budach W.
    Radiother Oncol; 2006 Jul 01; 80(1):33-8. PubMed ID: 16875750
    [Abstract] [Full Text] [Related]

  • 20. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
    Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ.
    Int J Oncol; 2006 May 01; 28(5):1141-51. PubMed ID: 16596230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.